TD Private Client Wealth’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-273
Closed -$3.25K 1258
2022
Q3
$3.25K Sell
273
-1,902
-87% -$27K ﹤0.01% 1086
2022
Q2
$27.7K Sell
2,175
-1,687
-44% -$21.7K ﹤0.01% 850
2022
Q1
$49.9K Buy
3,862
+3,769
+4,053% +$49.8K ﹤0.01% 772
2021
Q4
$1.47K Buy
93
+80
+615% +$1.37K ﹤0.01% 1038
2021
Q3
$253 Buy
+13
New +$258 ﹤0.01% 1205

Other funds holding SEM

TD Private Client Wealth's SEM Position: Q4 2022 in Review

TD Private Client Wealth sold out of Select Medical (SEM) in Q4 2022, closing a stake of 273 shares — an estimated $3.25K sold.

TD Private Client Wealth first reported a position in SEM in Q3 2021 and held it in 5 quarters. The position peaked at $49.9K in Q1 2022. 211 funds tracked by Wall St. Rank hold SEM as of Q4 2022.

  • TD Private Client Wealth reported no remaining Select Medical position as of Q4 2022 after selling out during the quarter.
  • TD Private Client Wealth sold 273 Select Medical shares in Q4 2022, an estimated $3.25K.
  • TD Private Client Wealth first reported a position in Select Medical in Q3 2021 and held it in 5 quarters.
  • TD Private Client Wealth's Select Medical position peaked at $49.9K in Q1 2022.
  • 211 funds tracked by Wall St. Rank held Select Medical as of Q4 2022.

Based on TD Private Client Wealth's 13F filing for Q4 2022, filed 16 Aug 2024.